Clinical Trial Update: Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adjuvant XELOX chemotherapy with concurrent capecitabine and radiotherapy for resected gastric cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: xie congying | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED